Q/C Technologies, Inc. Increase (Decrease) in Accounts Receivable, Related Parties
Q/C Technologies, Inc. (QCLS) reported Increase (Decrease) in Accounts Receivable, Related Parties of -$31.89 thousand for the 12-month period ending 2017-12-31, per its 10-K/A filed 2018-07-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2018-11-14
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2017-12-31 was $0.00.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2017-09-30 was $0.00.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2017-06-30 was -$24.43K.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2017-03-31 was -$7.46K.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for fiscal 2017 was -$31.89K, a 8492.63% decline from fiscal 2016.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for fiscal 2016 was $380.00.
- Q/C Technologies, Inc. increase (decrease) in accounts receivable, related parties for fiscal 2013 was $1.20M.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month as first filed | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month as first filed | Increase (Decrease) in Accounts Receivable, Related Parties 12 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-07-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | -$24.43K derived: sum of 3 quarters · filed 2018-11-14 | -$31.89K 10-K/A · filed 2018-07-13 | $93.11K 10-K · filed 2018-04-03 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$24.43K derived: sum of 2 quarters · filed 2018-11-14 | -$31.89K 10-Q · filed 2018-11-14 | $93.11K 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | -$24.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$31.89K 10-Q · filed 2018-08-14 | $93.11K 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | -$7.46K 10-Q · filed 2018-07-13 | ||||||
| 2016-12-31 | $380.00 10-K/A · filed 2018-07-13 | ||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $266.38K 10-Q · filed 2015-11-13 | $434.38K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | $266.38K 10-Q · filed 2015-08-18 | $434.38K derived: sum of 3 quarters · filed 2015-08-18 | $434.38K derived: sum of 4 quarters · filed 2015-08-18 | |||
| 2014-03-31 | $266.38K 10-Q · filed 2015-05-14 | $434.38K derived: sum of 2 quarters · filed 2015-05-14 | $434.38K derived: sum of 3 quarters · filed 2015-05-14 | $557.58K derived: sum of 4 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $168.00K derived: sum of 2 quarters · filed 2015-03-23 | $291.20K derived: sum of 3 quarters · filed 2015-03-23 | $1.20M 10-K · filed 2015-03-23 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $123.20K derived: sum of 2 quarters · filed 2014-11-13 | $1.03M 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $123.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $1.03M 10-Q · filed 2014-08-12 | |||||
| 2013-03-31 | $908.18K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |